Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Feeling abnormal, Hallucination, Headache, Magnetic resonance imaging
Clinical narrative: MEMORY LOSS; BLOOD CLOTS; AMNESIA; BRAIN FOG; CHEST CONGESTION; HALLUCINATIONS; COGNITIVE DYSFUNCTION; CONFUSION; INABILITY TO REGULATE BODY TEMPERATURE; TINGLING; CHEST PAIN; BLURRY VISION; SLURRED SPEECH; ARM PAIN; HEADACHES; FEVER AND CHILLS; MEMORY DISTURBANCE; SHORTNESS OF BREATH; TURN PURPLE WHEN COLD; LOW OXYGEN LEVELS; This spontaneous report received from a patient concerned a 37 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031,expiry: UNKNOWN) dose was not reported,1 total, administered on 20-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced memory loss, blood clots, amnesia, brain fog, chest congestion, hallucinations, cognitive dysfunction, confusion, inability to regulate body temperature, tingling, chest pain, blurry vision, slurred speech, arm pain, headaches, fever and chills, shortness of breath, mental disturbances and other problems in memory cycle. her oxygen saturation was 89 all the time and her color changed to purple when it is cold. She also reported that she is not able to speak very well. Patient was hospitalized on 16-APR-2021 for reactions to the shot. She was discharged on 20-APR-2021 and her PCP referred her to a neurologist because they "couldn't do anything else for her". She says the neurologist  refused to see her because she was having covid-19 symptoms. She was told they couldn't do anything for her blood clots because of where they were located and the only thing she could do was take a baby aspirin. She saw a speech therapist for her slurry speech. The patient also reported that she has a Terminal disease and that she cannot remember anything past the 16th and has to keep a log. Patient had an MRI and doctor said her head doesn't look good. The patient also stated that she is unable to return to work. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from memory loss, arm pain, amnesia, chest congestion, fever and chills, headaches, brain fog, cognitive dysfunction, confusion, inability to regulate body temperature, tingling, chest pain, blurry vision, hallucinations, blood clots, slurred speech, low oxygen levels, shortness of breath, mental disturbances and other problems in memory cycle. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: This concerned a 37 year old female patient unknown ethnicity, who, on an unspecified date after receiving the Janssen Covid-19 vaccine, amnesia, brain fog, hallucinations, cognitive dysfunction, confusion, mental disturbances, inability to regulate body temperature, fever and chills, tingling, chest congestion, chest pain, shortness of breath, blurry vision, slurred speech, arm pain, and other problems with in memory. She could not remember anything past the 16th of April (27 days after receiving the vaccine) and has to keep a log. Her oxygen saturation was 89 all the time and her color changed to purple when it is cold. MRI was done and doctor mentioned that her head doesn't look good. Twenty-seven (27) days after receiving the vaccine, patient was also admitted in the hospital and stayed for 4 days. Patient was suspected to have COVID symptoms, which is the reason why she would not be seen by the neurologist she was referred to; but advised her to take baby aspirin for the suspicion of having a blood clot, unknown location. The patient's weight, height were not reported. Medical and smoking history were not reported as well as concomitant medication, illicit drug use and alcohol abuse. Based on the available information, the relationship with Janssen Covid-19 vaccine is considered indeterminate per WHO causality classification of adverse events following immunization. More information (e.g. platelet count, fibrinogen, anti-platelet factor 4 antibodies, diagnostic imaging, medical records) will be sought when contact information becomes available.